menu ☰
menu ˟

CMS votes unanimously to maintain Medicare's reimbursement rate for Cologuard CRC screening test

27 Aug 2015
The CMS Advisory Panel on Clinical Diagnostic Laboratory Tests voted unanimously (11-0) to maintain Medicare’s current reimbursement rate of $492.72 for the Cologuard stool DNA screening test for colorectal cancer, Exact Sciences announced.The vote...

Click here to view the full article which appeared in Hematology Oncology

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.